Clinical Study
High Dose Rate Brachytherapy as a Treatment Option in Endobronchial Tumors
Table 1
Patients’ and tumor characteristics.
| Characteristic | Value |
| Median age (range), year | 70 (37–92) |
| Median follow-up (range), months | 17 (1.5–86) |
| Gender | | Male | 14 (61%) | Female | 9 (39%) |
| Smoking history | | Yes | 13 (65%) | No | 7 (35%) | Unknown | 3 |
| ECOG performance status | | 0 | 1 (4%) | 1 | 17 (74%) | 2 | 5 (22%) |
| Histology | | Primary lung tumor | 20 (87%) | SCC | 9 (39%) | Adenocarcinoma | 9 (39%) | Others | 2 (9%) | Lung metastases | 3 (13%) | Colon adenocarcinoma | 2 (9%) | Thymoma | 1 (4%) |
| Site | | Central (trachea, main bronchi) | 11 (48%) | Peripheral (lobar bronchi) | 12 (52%) |
| Previous lung tumor | | Yes | 16 (70%) | No | 7 (30%) |
| Treatment to previous lung tumor | | Surgery | 7 (30%) | Lobectomy | 4 (17%) | Pneumonectomy | 1 (4%) | Metastasectomy | 2 (9%) | Radiotherapy | 10 (43%) | Chemotherapy | 9 (39%) | Photodynamic therapy | 1 (4%) |
| Tumor visible on CT | 18 (78%) |
|
|
EBRT: external beam radiotherapy.
|